Omics & biomarkers
Genomics, transcriptomics and multi-omics integration for disease signatures.
AD Research
Analyse Evidence. Discover Solutions.
Integrating biological data, computational intelligence and nanotechnology for early diagnosis, biomarker discovery, therapeutic-target identification and personalised treatment.
Biological insight, computational intelligence and nanotechnology — unified for precision healthcare.
Genomics, transcriptomics and multi-omics integration for disease signatures.
Predictive models, docking, dynamics and in-silico therapeutic design.
Quantum dots, biosensors and nanomaterials for diagnosis and targeted therapy.
Two biomedical pillars driving biomarker discovery, early diagnosis and personalised therapy design.
Five interconnected domains — select a category to explore specific topics and directions.
Multi-cancer theranostics spanning genomics, biomarkers and targeted nanotherapeutics.
From quantum-dot synthesis to AI/ML model development — integrated methods for theranostic research.
Experimental nanobiotechnology paired with computational intelligence — from bench to in-silico validation.
Integrating biological data, computational intelligence and nanotechnology for early diagnosis, biomarker discovery and personalised theranostics.
Review published work, ongoing projects and pathways to partner on theranostics and precision medicine research.